Sign Out
Pregnancy: For PICOPREP no clinical data on exposed pregnancy are available. Studies in animals have shown reproductive toxicity. As picosulfate is a stimulant laxative, for safety measure, it is preferable to avoid the use of PICOPREP during pregnancy.
Fertility: Studies with PICOPREP in animals have shown no impairment of fertility or embryo-fetal toxicity. In studies with sodium picosulfate alone, embryofetal toxicity has been observed in rats and rabbits at very high doses (see Pharmacology: Toxicology: Preclinical Safety Data under Actions).
Breastfeeding: There is no experience with the use of PICOPREP in nursing mothers. It is not known whether this drug is excreted in human milk. It is advised to exercise caution when PICOPREP is administered to a nursing woman.
